this post was submitted on 03 Apr 2025
1 points (100.0% liked)

Public Health

638 readers
14 users here now

For issues concerning:

๐Ÿฉบ This community has a broader scope so please feel free to discuss. When it may not be clear, leave a comment talking about why something is important.

Related Communities

See the pinned post in the Medical Community Hub for links and descriptions. link (!medicine@lemmy.world)

Rules

Given the inherent intersection that these topics have with politics, we encourage thoughtful discussions while also adhering to the mander.xyz instance guidelines.

Try to focus on the scientific aspects and refrain from making overly partisan or inflammatory content

Our aim is to foster a respectful environment where we can delve into the scientific foundations of these topics. Thank you!

founded 2 years ago
MODERATORS
otter@mander.xyz
otter@lemmy.ca
1
Cholera vaccines for the rich, cholera for the poor (journals.plos.org)
submitted 1 month ago by TacoButtPlug@sh.itjust.works to c/publichealth@mander.xyz
0 comments fedilink hide all child comments
 

In October 2024, the global stockpile of oral cholera vaccine (OCV) ran dry yet again, leaving no unallocated doses for new or worsening outbreaks. This underscores the ongoing shortfall of tens of millions of doses, driven by growing need, with both cases and deaths increasing globally in recent years, and lack of supply, with only one manufacturer currently serving the global stockpile. Meanwhile, however, pharmaceutical companies are reaping profits from a booming parallel market for OCV for a much lower-risk population: travelers from high-income countries (HICs). The current situation, where a tourist from a HIC at essentially zero risk of dying from cholera has more ready access to vaccines than a resident of the endemic country they will visit, exemplifies the chasm between commercial priorities and global health needs.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here